BAYLIS PAIN MANAGEMENT SINGLE-USE PROBE— 510(k) K071745

Substantially Equivalent

Baylis Medical Co., Inc.

FDA 510(k) clearance K071745 for BAYLIS PAIN MANAGEMENT SINGLE-USE PROBE, Substantially Equivalent on 2007-07-19. Applicant: Baylis Medical Co., Inc..

Clearance details

Applicant: Baylis Medical Co., Inc.
Product code: Code GXI
Advisory panel: Neurology
Date received: 2007-06-27
Decision date: 2007-07-19
Decision: Substantially Equivalent
Clearance type: Special
Location: Mississauga, Ontario, CA

Download summary PDF View on FDA.gov ↗

Adverse events under product code GXI

product code GXI

Death: 3
Injury: 171
Total: 174

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.